Breaking News
Sort by:
Top Post
ProPharma Acquires UK Based Digital Lab Consulting
ProPharma Group (ProPharma) the leading global provider of regulatory, clinical, and quality services for the […]
Audax Private Equity Announces Acquisition of Medi-Weightloss, Inc.
Audax Private Equity announced the acquisition of Medi-Weightloss, a leading operator of science-based, physician-supervised weight-loss […]
Clarify Pharma Acquires Shares in Atai Life Sciences and Compass Pathways
Clarify Pharma, an investment vehicle specialising in biotech and life sciences companies seeking to prove […]
BioIVT Acquires Fidelis Research
BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, today […]
Concord Health Partners Adds Healthcare Private Equity Veteran Robert Schulz as Managing Director
Concord Health Partners (“Concord” or the “Firm”), a healthcare focused investment firm, today announced that […]
Gilead Sciences Completes Acquisition of MiroBio
GMiroBioilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction to […]
GENFIT Acquires Swiss Biotech Versantis for Over CHF105 Million
GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of […]
BioIVT Acquires XenoTech, a Leading Provider of Products and Services for Preclinical Testing of New Drug Candidates
BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, today […]
Spatial Biology CRO Flagship Biosciences Acquires Pharma Services Business from Interpace Biosciences
Flagship Biosciences, Inc., a leader in spatial biology and biomarker analytics services, announced the acquisition […]
Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio
AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, has been acquired by biotech investor […]
GSK Completes Acquisition of Affinivax, Inc.
GSK plc (LSE/NYSE: GSK) today announced it has completed the acquisition of Affinivax, Inc (Affinivax), a […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more